Drugs / CapulinTM
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03540966 | Jan 2018 → Jan 2019 | — | Xijing Hospital | Unknown | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT03973073 | Aug → Nov 2019 | vitiligo | Peking University People's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CapulinTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03973073 ↗ |
| Modality | Other / unclassified | “commercial camouflage agent” NCT03973073 ↗ |